W. A. van der Zwan

Salvage peptide receptor radionuclide therapy with [177Lu-DOTA,Tyr3]octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumours

E. Krenning, W. D. de Herder, W. A. van der Zwan, 2018, European Journal of Nuclear Medicine and Molecular Imaging.

Nephrotoxicity after PRRT with 177Lu-DOTA-octreotate

E. Krenning, K. Mauff, D. Kwekkeboom, 2016, European Journal of Nuclear Medicine and Molecular Imaging.

Pitfalls in the response evaluation after peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate.

E. Krenning, D. Kwekkeboom, W. D. de Herder, 2017, Endocrine-related cancer.

GEPNETs update: Radionuclide therapy in neuroendocrine tumors.

L. Kvols, D. Kwekkeboom, W. D. de Herder, 2014, European journal of endocrinology.

PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest

S. Severi, I. Drozdov, E. Krenning, 2019, European Journal of Nuclear Medicine and Molecular Imaging.

Probing intracellular motor protein activity using an inducible cargo trafficking assay.

Nanda Keijzer, C. Hoogenraad, Max A. Schlager, 2010, Biophysical journal.

Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors

E. Krenning, C. V. van Eijck, D. Kwekkeboom, 2017, Clinical Cancer Research.

NMDA Receptor Activation Suppresses Microtubule Growth and Spine Entry

C. Hoogenraad, Jeroen A. A. Demmers, J. Jaworski, 2011, The Journal of Neuroscience.

Probing intracellular motor protein activity using an inducible cargo trafficking assay.

C. Hoogenraad, Max A. Schlager, L. Kapitein, 2010, Biophysical journal.